drugset / Trial / NCT06637254
A Study to Evaluate the Efficacy and Safety of HSK31858 Tablets in Patients with Bronchial Asthma
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a phase II, randomised, double-blind, placebo-controlled, multicenter study to assess the efficacy and safety of HSK31858 in patients with bronchial asthma
Timeline
- Start
- 2024-10-22
- Primary completion
- 2026-03-22
- Completion
- 2026-09-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HSK31858 | Unknown | 20 mg | Oral |
| Subject | HSK31858 | Unknown | 40 mg | Oral |